Paul Laven, DO
Family Medicine · Mesa, AZNPI 1396718102
Payments from drug & device makers
Across 51 payments — averaging $44.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biohaven Pharmaceuticals, Inc.$1K
- AstraZeneca$183
- Abbott$164
- AbbVie$123
- Lucid Diagnostics Inc.$107
- Lilly USA, LLC$54
- plus $278 from 10 others
What the payments were for
- Consulting fees$1,20053%
- Food & beverage$1,06847%
- Education$60%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biohaven Pharmaceuticals, Inc. | 5 | $1,365 |
| AstraZeneca | 12 | $183 |
| Abbott | 3 | $164 |
| AbbVie(2 entities) | 7 | $123 |
| Lucid Diagnostics Inc. | 3 | $107 |
| Lilly USA, LLC | 3 | $54 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $48 |
| Boehringer Ingelheim | 3 | $44 |
| Amgen | 2 | $36 |
| Intuitive Surgical | 1 | $30 |
| Merck | 2 | $25 |
| Genentech USA, Inc. | 2 | $23 |
| Scilex Pharmaceuticals Inc. | 1 | $22 |
| Novartis | 1 | $20 |
| Pfizer | 1 | $18 |
| Novo Nordisk | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$1,324
- FreeStyle Libre 2$142
How this compares
$2,274 in reported general payments places this provider in the 80th percentile of 2,099 family medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 64 | $75,874 |
| EliquisApixaban | 45 | $54,548 |
| JardianceEmpagliflozin | 29 | $49,002 |
| XareltoRivaroxaban | 11 | $20,598 |
| MounjaroTirzepatide | 13 | $13,344 |
| Novolog FlexpenInsulin Aspart | 26 | $11,915 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 82 | $10,536 |
| JanuviaSitagliptin Phosphate | 11 | $6,059 |
| MovantikNaloxegol Oxalate | 11 | $4,682 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 14 | $3,391 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 70 | $3,169 |
| Atorvastatin Calcium | 305 | $2,294 |
| Ultra-Fine Short Pen NeedlePen Needle, Diabetic | 22 | $1,882 |
| Rosuvastatin Calcium | 172 | $1,791 |
| Gabapentin | 110 | $1,648 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $13 | $75,87464 claims |
| PfizerEliquis | $18 | $54,54845 claims |
| Boehringer IngelheimJardiance | $44 | $49,00229 claims |
| Lilly USA, LLCMounjaro | $54 | $13,34413 claims |
| MerckJanuvia | $25 | $6,05911 claims |
| AbbVieSynthroid | $123 | $1,23320 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,099 family medicine providers in Arizona.
Other family medicine in Mesa
- Terry O'ReillyMesa$35.8M
- Corey AndersonMesa$21.5M
- Gerald ShockeyMesa$12.3M
- Rachel GreatwoodMesa$1.5M
- Donna DesantisMesa$776K
- Yadwinder DhillonMesa$445K
- Benjamin ClarkMesa$441K
- Suzanne BentzMesa$174K
- William ReedyMesa$168K
- Allan SooMesa$129K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.